| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Sphingolipid pathway", "2": "Sphingolipid metabolism in senescence", "3": "Nonalcoholic fatty liver disease", "4": "Sphingolipid metabolism overview", "5": "Sphingolipid metabolism integrated pathway", "6": "Ferroptosis", "7": "Mitochondrial complex iv assembly", "8": "Copper homeostasis", "9": "Overlap between signal transduction pathways contributing to lmna laminopathies", "10": "Progeriaassociated lipodystrophy", "11": "Familial partial lipodystrophy fpld", "12": "Cholesterol metabolism with bloch and kandutschrussell pathways", "13": "Oxidative phosphorylation", "14": "Mitochondrial complex i assembly model oxphos system", "15": "Glycerophospholipid biosynthetic pathway", "16": "Cholesterol biosynthesis pathway", "17": "Allograft rejection", "18": "Ppar signaling pathway", "19": "Alzheimers disease", "20": "Calcium regulation in cardiac cells", "21": "Alzheimers disease and mirna effects", "22": "Envelope proteins and their potential roles in edmd physiopathology", "23": "Development of ureteric collection system", "24": "Mitochondrial long chain fatty acid betaoxidation", "25": "Fatty acid betaoxidation", "26": "G protein signaling pathways", "27": "Type i collagen synthesis in the context of osteogenesis imperfecta", "28": "Factors and pathways affecting insulinlike growth factor igf1akt signaling", "29": "Pi3kaktmtor signaling pathway and therapeutic opportunities", "30": "Proteasome degradation", "31": "Il18 signaling pathway", "32": "Genes controlling nephrogenesis", "33": "Angiopoietinlike protein 8 regulatory pathway"} |